Accounting Policies [Abstract] Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block] Earnings Per Common Share Attributable To Mylan Inc. Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Earnings Per Share [Abstract] Net earnings attributable to Mylan Inc. common shareholders Net Income (Loss) Available to Common Stockholders, Basic Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Basic Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Basic earnings per common share attributable to Mylan Inc. common shareholders Earnings Per Share, Basic Total dilutive shares outstanding Weighted Average Number of Shares Outstanding, Diluted Diluted earnings per common share attributable to Mylan Inc. Earnings Per Share, Diluted Segment Reporting [Abstract] Segment Information Segment Reporting Disclosure [Text Block] Income Tax Disclosure [Abstract] Statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent State income taxes and credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent Foreign rate differential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent Other foreign items Effective Income Tax Rate Reconciliation, Tax Settlement, Foreign, Percent Uncertain tax positions Effective Income Tax Rate Reconciliation, Tax Contingency, Percent Foreign tax credits, net Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent Valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Clean energy and research credits Effective Income Tax Rate Reconciliation Equity Investment Effective Income Tax Rate Reconciliation Equity Investment Effective Income Tax Rate Reconciliation, India Amagulation Effective Income Tax Rate Reconciliation, India Amagulation Effective Income Tax Rate Reconciliation, India Amagulation Other Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective tax rate Effective Income Tax Rate Reconciliation, Percent Quarterly Financial Data [Abstract] Supplementary Financial Information Quarterly Financial Information [Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Designated as hedging instrument Designated as Hedging Instrument [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Prepaid expenses and other current assets Prepaid Expenses and Other Current Assets [Member] Other assets Other Assets [Member] Other current liabilities Other Current Liabilities [Member] Derivative Instruments Risk [Axis] Derivative Instrument [Axis] Derivative Contract Type [Domain] Derivative Contract [Domain] Interest rate swaps Interest Rate Swap [Member] Foreign currency forward contracts Foreign Exchange Forward [Member] Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Asset Derivatives, Fair Value Derivative Asset, Fair Value, Gross Asset Liability derivatives, fair value Derivative Liability, Fair Value, Gross Liability Commitments [Abstract] Commitments. Supply Commitment [Table] Supply Commitment [Table] Supply Commitment [Axis] Supply Commitment [Axis] Supply Commitment Arrangement [Domain] Supply Commitment Arrangement [Domain] Generic Biologic Compounds Collaboration Generic Biologic Compounds Collaboration [Member] Generic Biologic Compounds Collaboration Type of Arrangement and Non-arrangement Transactions [Axis] Type of Arrangement and Non-arrangement Transactions [Axis] Arrangements and Non-arrangement Transactions [Domain] Arrangements and Non-arrangement Transactions [Domain] Theravance Biopharma Theravance Biopharma [Member] Theravance Biopharma Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent event Subsequent Event [Member] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Maximum Maximum [Member] Supply Commitment [Line Items] Supply Commitment [Line Items] Lease expenses Operating Leases, Rent Expense, Net Other current liabilities Business Combination, Contingent Consideration, Liability Insulin Analog Products Insulin Analog Products Insulin Analog Products Other commitment Other Commitment Collaborative agreement payment PaymentsToAcquireCollaborativeAgreement Payments to acquire collaborative agreement Equity method investments Equity Method Investments Development and sales milestone payments Development and sales milestone payments Development and sales milestone payments Financial Instruments And Risk Management Financial Instruments Disclosure [Text Block] Statement of Financial Position [Abstract] Statement [Table] Statement [Table] Statement, Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Statement [Line Items] Statement [Line Items] Assets Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Accounts receivable, net Accounts Receivable, Net, Current Inventories Inventory, Net Deferred income tax benefit Deferred Tax Assets, Net of Valuation Allowance, Current Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Total current assets Assets, Current Property, plant and equipment, net Property, Plant and Equipment, Net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Goodwill Goodwill Deferred income tax benefit Deferred Tax Assets, Net of Valuation Allowance, Noncurrent Other assets Other Assets, Noncurrent Total assets Assets Liabilities and Equity Liabilities and Equity [Abstract] Liabilities Liabilities [Abstract] Current liabilities: Liabilities, Current [Abstract] Trade accounts payable Accounts Payable, Trade, Current Short-term borrowings Short-term Debt Income taxes payable Accrued Income Taxes, Current Current portion of long-term debt and other long-term obligations Long-term Debt, Current Maturities Deferred income tax liability Deferred Tax Liabilities, Net, Current Other current liabilities Other Liabilities, Current Total current liabilities Liabilities, Current Long-term debt Long-term Debt, Excluding Current Maturities Other long-term obligations Other Liabilities, Noncurrent Deferred income tax liability Deferred Tax Liabilities, Net, Noncurrent Total liabilities Liabilities Equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Mylan Inc. shareholders’ equity Stockholders' Equity Attributable to Parent [Abstract] Common stock — par value $0.50 per share Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Retained earnings Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total Mylan Inc. shareholders' equity, before treasury stock StockholdersEquityParentBeforeTreasuryStock Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings that are attributable to the parent company, excluding equity attributable to noncontrolling interests, and before deducting the carrying value of treasury stock. Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Less: Treasury stock — at cost Treasury Stock, Value Total equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and equity Liabilities and Equity Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Information by Financial Statement Line Item [Axis] Information by Financial Statement Line Item [Axis] Financial Statement Classification [Domain] Financial Statement Classification [Domain] Financial Statement Classification [Domain] Net Revenues Sales Revenue, Goods, Net [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Allergy Allergy [Member] Allergy [Member] Anti-infectives Anti Infective Agents [Member] Anti Infective Agents [Member] Cardiovascular Cardiovascular [Member] Cardiovascular [Member] Central Nervous System Central Nervous System [Member] Central Nervous System [Member] Dermatological Dermatological [Member] Dermatological Endocrine and Metabolic Endocrine And Metabolic [Member] Endocrine And Metabolic [Member] Gastrointestinal Gastrointestinal [Member] Gastrointestinal [Member] Renal and Genitourinary Agents Renal and Genitourinary Agents [Member] Renal and Genitourinary Agents Respiratory System Respiratory Agents [Member] Respiratory Agents [Member] Other Other Products [Member] Other Products [Member] Product Information [Line Items] Product Information [Line Items] Net sales Sales Revenue, Goods, Net Therapeutic class disclosure threshold Therapeutic Class Reporting Threshold Threshold for disclosure of individual therapeutic class, percentage of total category Equity [Abstract] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Gains and Losses on Derivatives in Cash Flow Hedging Relationships Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member] Gains and Losses on Marketable Securities Accumulated Net Unrealized Investment Gain (Loss) [Member] Defined Benefit Plan Items Accumulated Defined Benefit Plans Adjustment [Member] Foreign Currency Translation Adjustment Accumulated Translation Adjustment [Member] Accumulated Other Comprehensive Earnings (Loss) Accumulated Other Comprehensive Income (Loss) [Member] Foreign currency forward contracts Foreign Exchange Contract [Member] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Net unrecognized gains (losses) on derivatives, net of tax, beginning of period Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Net unrealized gains on marketable securities, net of tax, beginning of period Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax Net unrecognized losses and prior service cost related to defined benefit plans, net of tax, beginning of period Accumulated Other Comprehensive Income (Loss), Pension and Other Postretirement Benefit Plans, Net of Tax Foreign currency translation adjustment, beginning of period Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Accumulated other comprehensive loss, net of tax, beginning of period Other comprehensive (loss) earnings before reclassifications, before tax Other Comprehensive Income (Loss), before Reclassifications, before Tax Interest expense Interest Expense Other (expense) income, net Other Nonoperating Income (Expense) Amortization of prior service costs included in SG&A expenses Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax Amortization of actuarial loss included in SG&A expenses Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax Net other comprehensive earnings (loss), before tax Income (Loss) from Continuing Operations before Income Taxes, Extraordinary Items, Noncontrolling Interest Other comprehensive earnings (loss), before tax Other Comprehensive Income (Loss), before Tax Income tax related to items of other comprehensive (loss) earnings, derivatives Income Tax Expense (Benefit) Net unrecognized gains (losses) on derivatives, net of tax, end of period Net unrealized gains on marketable securities, net of tax, end of period Net unrealized gains on marketable securities, net of tax, end of period Foreign currency translation adjustment, end of period Accumulated other comprehensive loss, net of tax, end of period Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments and Tax Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Reclassification Adjustments and Tax Other Comprehensive Income (Loss), Reclassification of Defined Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Costs, before Tax Other Comprehensive Income (Loss), Reclassification of Defined Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Costs, before Tax Other Comprehensive Income (Loss), Reclassification of Defined Benefit Plans, Net Gain (Loss) Recognized in Net Periodic Benefit Costs, before Tax Change in unrecognized (loss) gain and prior service cost related to defined benefit plans Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Adjustment, before Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax Net unrecognized gain (loss) on derivatives Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, before Tax Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, before Tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax Net unrealized (loss) gain on marketable securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, before Tax Business Combinations [Abstract] Acquisitions and Other Transactions Business Combination Disclosure [Text Block] Deferred tax assets: Deferred Tax Assets, Net [Abstract] Deferred tax assets, employee benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits Deferred tax assets, accounts receivable allowances Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts Deferred tax assets, tax credits and loss carryforwards Deferred Tax Assets, Tax Credit Carryforwards Deferred tax assets, intangible assets and goodwill Deferred Tax Assets Intangible Assets Deferred Tax Assets Intangible Assets Deferred tax assets, convertible debt Deferred Tax Assets Convertible Debt Deferred tax assets convertible debt. Deferred tax assets, other Deferred Tax Assets, Other Total deferred tax assets, gross Deferred Tax Assets, Gross Valuation allowance Deferred Tax Assets, Valuation Allowance Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Deferred tax liabilities: Deferred Tax Liabilities, Net [Abstract] Deferred tax liabilities, plant and equipment Deferred Tax Liabilities, Property, Plant and Equipment Deferred tax liabilities, intangible assets Deferred Tax Liabilities, Intangible Assets Deferred tax liabilities, financial instruments Deferred Tax Liabilities, Derivatives Deferred tax liabilities, other Deferred Tax Liabilities, Other Total deferred tax liabilities Deferred Tax Liabilities, Gross Deferred tax assets (liabilities), net Deferred Tax Assets, Net Number of reportable segments Number of Reportable Segments Debt Disclosure [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Cash Convertible Notes Cash Convertible Notes [Member] Cash convertible notes. Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Convertible Debt Convertible Debt [Member] Call option Call Option [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Outstanding principal Debt Instrument, Face Amount Equity component carrying amount Debt Instrument, Convertible, Carrying Amount of Equity Component Unamortized discount Debt Instrument, Unamortized Discount Notes and Loans Payable, Current Notes and Loans Payable, Current Net debt carrying amount Long-term Debt Purchased call options Investment Owned, at Fair Value Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Old Warrants Old Warrants [Member] Old Warrants [Member] New Warrants New Warrants [Member] New Warrants [Member] Face amount of debt Trading Days - Consecutive Trading Days - Consecutive Debt instrument, interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Number of common stock issuable for warrants Class of Warrant or Right, Number of Securities Called by Warrants or Rights Exercise price of warrants issued Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants exchanged in amended transaction Number of warrants exchanged Number of warrants exchanged Ratio of observed share price to conversion reference price Ratio Of Observed Share Price To Conversion Reference Price Ratio Of Observed Share Price To Conversion Reference Price Reference Principal Amount Reference Principal Amount Of Cash Convertible Notes Reference principal amount of Cash Convertible Notes to which the ratio is applied to the debt for purposes of determining the number of shares of the equity security into which the debt will be converted. Percent of closing price of common stock and conversion reference rate Percent Of Closing Price Of Common Stock And Conversion Reference Rate Percent of the product of the closing price of common stock on a certain day and the applicable conversion reference rate Conversion reference price Debt Instrument, Convertible, Conversion Price Conversion reference rate, per reference principal amount Debt Instrument, Convertible, Conversion Ratio Number of Trading Days Number of Trading Days Unamortized discount Notes and Loans Payable, Current Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Litigation Case [Axis] Litigation Case [Axis] Litigation Case Type [Domain] Litigation Case [Domain] Modafinil Antitrust Litigation and FTC Inquiry Modafinil Antitrust Litigation and FTC Inquiry [Member] Modafinil Antitrust Litigation and FTC Inquiry. Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Other drug manufacturers Other Companies [Member] Other companies Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of defendants Loss Contingency, Number of Defendants Income Tax Contingency [Table] Income Tax Contingency [Table] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] State and local jurisdiction State and Local Jurisdiction [Member] Foreign country Foreign Tax Authority [Member] Frequency [Axis] Frequency [Axis] Frequency [Axis] Frequency [Domain] Frequency [Domain] [Domain] for Frequency [Axis] Carried forward indefinitely Indefinite [Member] Indefinite amount of time Income Tax Contingency [Line Items] Income Tax Contingency [Line Items] Amount of unrecognized deferred tax liability Deferred Tax Liability Not Recognized, Amount of Unrecognized Deferred Tax Liability, Undistributed Earnings of Foreign Subsidiaries Deferred tax assets, goodwill Deferred Tax Assets, Goodwill and Intangible Assets Valuation allowance, amount Change in valuation allowance, deferred tax asset Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Net operating loss carryforwards Operating Loss Carryforwards Capital loss carryforward Capital Loss Carryforward Capital loss carryforward. Credit carryforward Tax Credit Carryforward, Amount Unrecognized tax benefit Unrecognized Tax Benefits Unrecognized tax benefits that impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate Accrued interest and penalties Income Tax Examination, Penalties and Interest Accrued Interest expense (income) related to uncertain tax positions Income Tax Examination, Interest Expense Estimated change in unrecognized tax benefits possible within next 12 months, lower bound Significant (Increase) Decrease in Unrecognized Tax Benefits is Reasonably Possible, Estimated Range of Change, Lower Bound Schedule Of Operating Leases Operating Leases of Lessee Disclosure [Table Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Valuation and Qualifying Accounts [Abstract] Schedule II - Valuation and Qualifying Accounts Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Unrecognized tax benefit — beginning of year Additions for current year tax positions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Additions for prior year tax positions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Reductions for prior year tax positions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Reductions due to expirations of statute of limitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Addition due to acquisition Unrecognized Tax Benefits, Increase Resulting from Acquisition Unrecognized tax benefit — end of year Summary of Long-Term Debt Schedule of Debt [Table Text Block] Minimum Repayments on Outstanding Borrowings Schedule of Maturities of Long-term Debt [Table Text Block] Contingencies Legal Matters and Contingencies [Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] New Mylan New Mylan [Member] New Mylan Abbott Laboratories Abbott Laboratories [Member] Abbott Laboratories Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] CommonStockToOrdinaryShares CommonStockToOrdinaryShares [Member] CommonStockToOrdinaryShares [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Product rights and licenses Licensing Agreements [Member] Equity Interest Type [Axis] Equity Interest Type [Axis] Equity Interest Issued or Issuable, Type [Domain] Equity Interest Issued or Issuable, Type [Domain] Business Acquisition [Line Items] Business Acquisition [Line Items] Consideration transferred, shares Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Common stock, conversion basis Conversion of Stock, Shares Converted Conversion of Stock, Shares Issued Conversion of Stock, Shares Issued Voting interest acquired, percentage Business Acquisition, Percentage of Voting Interests Acquired Number of products Number Of Products Acquisition purchase price Business Combination, Consideration Transferred Acquisition related costs Business Acquisition, Transaction Costs Acquired intangible assets, weighted average useful life, in years Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Accounting Policies [Table] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Accounts Receivable Accounts Receivable [Member] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Domain] Machinery and equipment Machinery and Equipment [Member] Buildings and improvements Building and Building Improvements [Member] Software and Software Development Costs Software and Software Development Costs [Member] Minimum Minimum [Member] Short-term Debt, Type [Axis] Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Short-term Debt, Type [Domain] Working Capital Facilities Working Capital Facilities [Member] Working capital facilities that are secured by current assets and property, plant and equipment Receivables Facility Receivables Facility [Member] Receivables facility. Accounting Policies [Line Items] Property, Plant and Equipment [Line Items] Concentration risk, percentage Concentration Risk, Percentage Concentration risk, number of customers Concentration risk, number of major customers Concentration risk, number of major customers Total allowances for doubtful accounts Allowance for Doubtful Accounts Receivable Property, plant and equipment, estimated service life (years) Property, Plant and Equipment, Useful Life Capitalized Computer Software, Net Capitalized Computer Software, Net Depreciation expense Depreciation Finite-lived intangible asset, estimated useful life, in years Finite-Lived Intangible Asset, Useful Life Short-term borrowings, weighted average interest rate Short-term Debt, Weighted Average Interest Rate Accounts receivable securitization facility maximum borrowing capacity Accounts Receivable Facility Maximum Borrowing Capacity Accounts receivable facility maximum borrowing capacity. Accounts receivable from securitization Accounts Receivable from Securitization Sales allowances, current Sales Allowances Current Sales allowances that are recorded in a contra account to accounts receivable. Accrued sales allowances and other adjustments Accrued Sales Allowances Other Current Certain sales allowances and other adjustments that are paid to indirect customers. Aggregate principal amount Aggregate amount of warrants issued Exercise price of warrants issued Weighted average number diluted shares outstanding adjustment, stock-based awards and warrants Weighted Average Number Diluted Shares Outstanding Adjustment Stock repurchased during period, shares Treasury Stock, Shares, Acquired Stock repurchased during period, value Treasury Stock, Value, Acquired, Cost Method Anti-dilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Intellectual Property Developed Technology Rights [Member] Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Number of times damages may be increased in cases of willful infringement Business Combination [Abstract] Business Combination [Abstract] Famy Care Famy Care [Member] Famy Care Arixtra Arixtra Injection [Member] Arixtra Injection; asset acquisition Other companies Other acquisitions Series of Individually Immaterial Business Acquisitions [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] INDIA INDIA Business Segments [Axis] Segments [Axis] Segment [Domain] Segments [Domain] Generics Segment Generics Segment [Member] Generics Segment. Purchase consideration, contingent consideration, maximum Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Cash paid to acquire asset Payments to Acquire Businesses, Gross Escrow Deposit Escrow Deposit Identified intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Purchase price allocation, goodwill Number of businesses acquired Number of Businesses Acquired Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Finite-Lived Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Schedule of Intangible Assets by Major Class [Table] Patents and technologies Patents [Member] Other Other Intangible Assets [Member] Intangible Assets Excluding Goodwill [Line Items] Finite-Lived Intangible Assets [Line Items] Finite-lived intangible assets, original cost Finite-Lived Intangible Assets, Gross Finite-lived intangible assets, accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Finite-lived intangible assets, net book value Finite-Lived Intangible Assets, Net In-process research and development Indefinite-Lived Intangible Assets (Excluding Goodwill) Intangible assets, gross, excluding goodwill Intangible Assets, Gross (Excluding Goodwill) Intangible assets, net book value, exclduing goodwill Document And Entity Information [Abstract] Document and Entity Information. Document Information [Table] Document Information [Table] Document Information, Document [Axis] Document Information, Document [Axis] Document [Domain] Document [Domain] Document Information [Line Items] Document Information [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Current Fiscal Year End Date Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Current Reporting Status Entity Current Reporting Status Entity Filer Category Entity Filer Category Entity Public Float Entity Public Float Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Components of Other Comprehensive Loss Comprehensive Income (Loss) [Table Text Block] Balance Sheet Components [Abstract] Balance Sheet Components Inventories Schedule of Inventory, Current [Table Text Block] Property, plant and equipment Property, Plant and Equipment [Table Text Block] Other current liabilities Schedule of Accrued Liabilities [Table Text Block] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Specialty Segment Specialty Segment [Member] Specialty Segment. Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] Intersegment Intersegment Eliminations [Member] Corporate / Other Corporate Non-Segment and Elimintaions [Member] Corporate non-segment and elimintaions Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Total revenues Revenue, Net Segment profitability Operating Income (Loss) Schedule of Product Rights and Licenses by Therapeutic Class [Table] Schedule of Product Rights and Licenses by Therapeutic Class [Table] Schedule of Product Rights and Licenses by Therapeutic Class Antineoplastic Antineoplastic [Member] Antineoplastic Hematological Agents Hematological Agents [Member] Hematological Agents Schedule of Product Rights and Licenses by Therapeutic Class [Line Items] Schedule of Product Rights and Licenses by Therapeutic Class [Line Items] [Line Items] for Schedule of Product Rights and Licenses by Therapeutic Class Finite-lived intangible assets, net Major Customers [Abstract] Major Customers [Abstract] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Net sales Sales Revenue, Net [Member] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] McKesson Corporation McKesson Corporation [Member] McKesson Corporation [Member] AmeriSourceBergen Corporation AmeriSourceBergen Corporation [Member] AmeriSourceBergen Corporation Cardinal Health Inc Cardinal Health Inc [Member] Cardinal Health Inc [Member] Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Pricing and Medicaid Litigation Pricing And Medicaid Litigation [Member] Pricing and Medicaid Litigation. Indemnification agreement Indemnification Agreement [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Mylan Specialty Mylan Specialty [Member] Mylan Specialty Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Plan Name [Axis] Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] Long Term Incentive Plan 2003 Long Term Incentive Plan 2003 [Member] Long-Term Incentive 2003 Plan. Program Name [Axis] Program Name [Axis] Program Name Program Name [Domain] Program Name [Domain] [Domain] for Program Name 2014 Program 2014 Program [Member] 2014 Program Award Type [Axis] Award Type [Axis] Award Type [Domain] Equity Award [Domain] Stock options Employee Stock Option [Member] Stock appreciation rights and performance shares Stock appreciation rights and performance shares [Member] Stock appreciation rights and performance shares Stock appreciation rights Stock Appreciation Rights (SARs) [Member] Performance Shares Performance Shares [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Expected term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Forfeiture rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Forfeiture Rate Share-based compensation arrangement bysShare-based payment award, fair value assumptions, Forfeiture rate Weighted average grant date fair value per option Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Derivative, by Nature [Axis] Derivative, by Nature [Axis] Derivative, Name [Domain] Derivative, Name [Domain] Terminated Terminated [Member] Terminated Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Interest expense Interest Expense [Member] Other expense (income), net Other Expense [Member] Other expense (income), net Other Income [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Fair value hedging Fair Value Hedging [Member] 2016 Senior Notes (1.800% coupon) SeniorNotesTwoThousandSixteen1.8Percent [Member] Senior notes two thousand sixteen - 1.8 percent 2018 Senior Notes (6.000% coupon) Senior Notes Two Thousand And Eighteen - 6 Percent [Member] Senior notes two thousand and eighteen - 6 percent Senior Notes Senior Notes [Member] Loans payable Loans Payable [Member] Extinguishment of Debt [Axis] Extinguishment of Debt [Axis] Extinguishment of Debt, Type [Domain] Extinguishment of Debt, Type [Domain] Redemption premium Redemption Premium [Member] redemption premium 2016 Senior Notes (1.350% coupon) SeniorNotesTwoThousandSixteen1.35Percent [Member] Senior notes two thousand sixteen - 1.35 percent 2019 Senior Notes (2.550% coupon) SeniorNotesTwoThousandNineteen [Member] Senior notes two thousand nineteen 2023 Senior Notes (4.200% coupon) SeniorNotesTwoThousandTwentyThree4.2Percent [Member] Senior notes two thousand twenty three - 4.2 percent 2043 Senior Notes (5.400% coupon) SeniorNotesTwoThousandFortyThree [Member] Senior notes two thousand forty three Senior Notes issued in November 2013 Senior Notes issued in November 2013 [Member] Senior Notes issued in November 2013 2018 Senior Notes (2.600% coupon) Senior Notes Two Thousand Eighteen - 2.6 Percent [Member] Senior Notes Two Thousand Eighteen - 2.6% [Member] U.S. Term Loans U.S. Term Loans [Member] U.S. Term Loans 2017 Senior Notes (7.625% coupon) Senior Notes Two Thousand Seventeen [Member] Senior Notes Two Thousand Seventeen [Member] Long-term debt, gross Long-term Debt, Gross Amount of (Loss) or Gain Recognized in Earnings on Hedging Items Gain (Loss) on Fair Value Hedges Recognized in Earnings Long-term debt Repayments of debt Repayments of Debt Total redemption amount Extinguishment of Debt, Amount Redemption premium Gains (Losses) on Extinguishment of Debt Compensation and Retirement Disclosure [Abstract] Employee Benefits Pension and Other Postretirement Benefits Disclosure [Text Block] Agila Specialties Agila Specialties Private Limited [Member] Agila Specialties Private Limited Schedule of Purchase Price Allocation Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Business Acquisition, Pro Forma Information for Agila Acqusition Business Acquisition, Pro Forma Information [Table Text Block] Legal and professional accruals, including litigation accruals Estimated Litigation Liability, Current Payroll and employee benefit plan accruals Employee-related Liabilities, Current Accrued sales allowances Accrued interest Interest Payable, Current Fair value of financial instruments Derivative Instruments and Hedges, Liabilities Other Other Sundry Liabilities, Current Other current liabilities Performance awards Restricted Stock [Member] Vesting Period [Axis] Vesting Period [Axis] Vesting Period [Axis] Vesting Period [Domain] Vesting Period [Domain] [Domain] for Vesting Period [Axis] Vest ratably over two years Vest Ratably Over Two Years [Member] Vest Ratably Over Two Years Vest ratably over three years Vest Ratably Over Three Years [Member] Vest Ratably Over Three Years Vest In Four Years Vest In Four Years [Member] Vest In Four Years Vest after one year Vest After Five Years [Member] Vest After Five Years Vest After Three Years Vest After Three Years [Member] Vest After Three Years Vest after two years Vest After Two Years [Member] Vest After Two Years [Member] Vest After One Year Vest After One Year [Member] Vest After One Year [Member] Vest Two Thirds After Two Years Vest Two Thirds After Two Years [Member] Vest Two Thirds After Two Years Common stock shares reserved for issuance to employees Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Stock option award vesting period, in years Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Stock option award expiration period, in years Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Average remaining contractual term for options outstanding, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Average remaining contractual term for options vested and expected to vest, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Average remaining contractual term for options exercisable, in years Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Aggregate intrinsic value for options outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Aggregate intrinsic value for options vested and expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Aggregate intrinsic value for options exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Number of restricted stock awards, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Total unrecognized compensation expense, net of estimated forfeitures Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized Weighted-average period over which total unrecognized compensation expense expected to be recognized (years) Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Intrinsic value of stock-based awards exercised and restricted stock units converted Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period, Total Intrinsic Value And Equity Instruments Other Than Options, Vested In Period, Intrinsic Value Shares granted under 2015 program 2015 Operating Leases, Future Minimum Payments Due, Next Twelve Months 2016 Operating Leases, Future Minimum Payments, Due in Two Years 2017 Operating Leases, Future Minimum Payments, Due in Three Years 2018 Operating Leases, Future Minimum Payments, Due in Four Years 2019 Operating Leases, Future Minimum Payments, Due in Five Years Thereafter Operating Leases, Future Minimum Payments, Due Thereafter Total operating lease minimum commitments Operating Leases, Future Minimum Payments Due Product Liability Product Liability [Member] Product Liability Loss contingency accrual Loss Contingency Accrual Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Cash conversion feature of Cash Convertible Notes Cash Conversion Feature Of Cash Convertible Notes [Member] Cash conversion feature of cash convertible notes. Purchased cash convertible note hedge Purchased Cash Convertible Note Hedge [Member] Purchased cash convertible note hedge. Other expense (income), net Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Amount of Gain or (Loss) Recognized in Earnings on Derivatives Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Commitments Commitments Disclosure [Text Block] Summary Of Significant Accounting Policies Significant Accounting Policies [Text Block] RedemptionOption [Axis] RedemptionOption [Axis] RedemptionOption [Domain] RedemptionOption [Domain] [Domain] for Option one OptionOne [Member] Option two OptionTwo [Member] Revolving Facility Revolving Credit Facility [Member] Other Other Long Term Debt [Member] Other long term debt. 2020 Senior Notes (7.875% coupon) Senior Notes Two Thousand Twenty [Member] Senior Notes Two Thousand Twenty [Member] 2023 Senior Notes (3.125% coupon) SeniorNotesTwoThousandTwentyThree3.125Percent [Member] Senior notes two thousand twenty three - 3.125 percent Long-term debt, current maturities Long-term debt, excluding current maturities Equivalent percentage of redeemed amount Equivalent Price Percentage Of Principal Amount Redeemable Percentage price equivalent at which long-term debt principal amount is redeemable prior to a specified date. Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Debt Instrument, Redemption Price, Percentage Debt Instrument, Redemption Price, Percentage Derivative [Table] Derivative [Table] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Floating Rate Floating Rate Debt [Member] Floating Rate Debt [Member] Other operating (income) expense Other Operating Income (Expense) [Member] Effective November 2013 Effective November 2013 [Member] Effective November 2013 Effective December 2014 to August 2015 Effective December 2014 to August 2015 [Member] Effective dates ranging from December 2014 to August 2015 Cash flow hedging Cash Flow Hedging [Member] Net investment hedging relationships Net Investment Hedging [Member] Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts [Axis] Measurement Basis [Axis] Fair Value, Disclosure Item Amounts [Domain] Fair Value Measurement [Domain] Change during period, fair value disclosure Changes Measurement [Member] Contingent consideration Contingent Consideration [Member] Contingent Consideration. Derivative [Line Items] Derivative [Line Items] Interest rate cash flow hedge loss reclassified to net earnings Interest Rate Cash Flow Hedge Gain (Loss) Reclassified to Earnings, Net Notional amount of derivative Derivative, Notional Amount Loss on cash flow hedge ineffectiveness Loss on Cash Flow Hedge Ineffectiveness Maturity, years Derivative, Remaining Maturity Maximum length of time hedged in cash flow hedge, in years Maximum Length of Time Hedged in Cash Flow Hedge Amount of loss recognized in earnings on derivatives Derivative, Gain (Loss) on Derivative, Net Debt instrument, interest rate at period end Liability derivatives, fair value Fair value of credit risk derivatives Credit Risk Derivatives, at Fair Value, Net Pre-tax net losses on cash flow hedges to be reclassified from AOCE into earnings in next twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Rate used to discount net cash inflows to present values Fair Value Inputs, Discount Rate Payments for contingent consideration Payments of Merger Related Costs, Financing Activities Purchase consideration, contingent consideration Adjustment to contingent consideration liability Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Accretion expense Accretion Expense Mylan Laboratories Limited Subsidiaries [Member] Mylan Parent Company [Member] EU Commission Proceedings Perindorpril EU Commission Proceedings Perindorpril [Member] EU Commission Proceedings Perindorpril EU Commission Proceedings Citalopram EU Commission Proceedings Citalopram [Member] EU Commission Proceedings Citalopram Antitrust Proceedings Antitrust Proceedings [Member] Antitrust proceedings Loss contingency accrual Loss Contingency, Damages Paid, Value Damages awarded Loss Contingency, Damages Awarded, Value Income Statement [Abstract] Revenues: Revenue, Net [Abstract] Other revenues Other Revenue, Net Total revenues Cost of sales Cost of Goods and Services Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Litigation settlements, net Gain (Loss) Related to Litigation Settlement Other operating (income) expense, net Other Operating Income (Expense), Net Total operating expenses Operating Expenses Earnings from operations Interest expense Other expense (income), net Earnings before income taxes and noncontrolling interest Income tax provision Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net earnings attributable to the noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Net earnings attributable to Mylan Inc. common shareholders Earnings per common share attributable to Mylan Inc. common shareholders: Basic (in USD per share) Diluted (in USD per share) Weighted average common shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic Diluted Schedule of Short-term Debt Instruments [Table] Schedule of Short-term Debt [Table] Short-term Debt [Line Items] Short-term Debt [Line Items] Securitized accounts receivable Interest rate on borrowings Accounts Receivable Facility Interest Rate At Period End Accounts receivable facility interest rate at the end of the reporting period. 2015 Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2016 Long-term Debt, Maturities, Repayments of Principal in Year Two 2017 Long-term Debt, Maturities, Repayments of Principal in Year Three 2018 Long-term Debt, Maturities, Repayments of Principal in Year Four 2019 Long-term Debt, Maturities, Repayments of Principal in Year Five Thereafter Long-term Debt, Maturities, Repayments of Principal after Year Five Total Fair value of long-term debt Debt Instrument, Fair Value Disclosure Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities, Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Debt securities Debt Securities [Member] Equity securities Equity Securities [Member] Schedule of Available-for-sale Securities [Line Items] Schedule of Available-for-sale Securities [Line Items] Amortized Cost Available-for-sale Securities, Amortized Cost Basis Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Fair Value Available-for-sale Securities Not designated as hedging instrument Not Designated as Hedging Instrument [Member] Other assets Current portion of long-term debt Current Portion of Long-Term Debt [Member] Long-term debt Long-term Debt [Member] Current assets (excluding inventories) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Inventories Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Property, plant and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment In-process research and development Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Other assets (including equity method investment) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Total assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent Other non-current liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other Net assets acquired Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Schedule of Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Land and improvements Land and Land Improvements [Member] Construction in progress Construction in Progress [Member] Property, Plant and Equipment [Line Items] Property, plant and equipment, gross Property, Plant and Equipment, Gross Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, net Nature of Operations Nature of Operations [Text Block] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] In-process research and development In Process Research and Development [Member] Amortization expense Amortization of Intangible Assets Impairment charge, intangible assets Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) Expected amortization expense, 2015 Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months Expected amortization expense, 2016 Finite-Lived Intangible Assets, Amortization Expense, Year Two Expected amortization expense, 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Three Expected amortization expense, 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Four Expected amortization expense, 2019 Finite-Lived Intangible Assets, Amortization Expense, Year Five Discount rate used in valuation of in-process research and development Acquired in-process research and development assets reclassified to product rights and licenses Intangible Assets Reclassified from Non Amortizable to Amortizable Intangible assets reclassified from non amortizable to amortizable Impairment of products rights and licenses intangible assets Impairment of Intangible Assets, Finite-lived Payment to acquire intangible assets Payments to Acquire Intangible Assets Comprehensive Earnings Comprehensive Income (Loss) Note [Text Block] Changes in carrying amount of goodwill Schedule of Goodwill [Table Text Block] Components of intangible assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Product rights and licenses by therapeutic category Product Rights And Licenses By Therapeutic Category [Table Text Block] Product rights and licenses by therapeutic category Cash flow hedging relationships Net sales Sales [Member] Amount of (Loss) or Gain Recognized in AOCE (Net of Tax) on Derivative (Effective Portion) Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Amount of Loss Reclassified from AOCE into Earnings (Effective Portion) Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Amount of Gain Excluded from the Assessment of Hedge Effectiveness Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] United States UNITED STATES Other Other Americas [Member] Other Americas [Member] Europe Europe [Member] Rest of World Segment Geographical Groups Of Countries Group Three [Member] Segment Geographical Groups Of Countries Group Three [Member] France FRANCE Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Income tax provision (benefit), Federal, current Current Federal Tax Expense (Benefit) Income tax provision (benefit), Federal, deferred Deferred Federal Income Tax Expense (Benefit) Income tax provision (benefit), Federal Federal Income Tax Expense (Benefit), Continuing Operations Income tax provision (benefit), State and Puerto Rico, current Current State and Local Tax Expense (Benefit) Income tax provision (benefit), State and Puerto Rico, deferred Deferred State and Local Income Tax Expense (Benefit) Income tax provision (benefit), State and Puerto Rico State and Local Income Tax Expense (Benefit), Continuing Operations Income tax provision (benefit), Foreign, current Current Foreign Tax Expense (Benefit) Income tax provision (benefit), Foreign, deferred Deferred Foreign Income Tax Expense (Benefit) Income tax provision (benefit), Foreign Foreign Income Tax Expense (Benefit), Continuing Operations Income tax provision Earnings (loss) before income taxes and noncontrolling interest: Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest [Abstract] Earnings before income taxes and noncontrolling interest, domestic Income (Loss) from Continuing Operations before Income Taxes, Domestic Earnings before income taxes and noncontrolling interest, foreign Income (Loss) from Continuing Operations before Income Taxes, Foreign Earnings before income taxes and noncontrolling interest Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Schedule of Components of Income Tax Provision Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Statutory Tax Rate to Effective Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Schedule of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns Roll Forward [Table Text Block] Stock-Based Incentive Plan Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Postretirement Benefits, Type of Deferred Compensation [Axis] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Axis] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain] Other Postretirement Benefits, Individual Contracts, Type of Deferred Compensation [Domain] Base Salary Deferred Base Salary [Member] Deferred Base Salary [Member] Deferred Bonus Deferred Bonus [Member] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Accrued benefit obligation Defined Benefit Plan, Accumulated Benefit Obligation Defined contribution plan, maximum annual contribution per employee, percent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent Total employer contributions Defined Contribution Plan, Cost Recognized Multiemployer plans, withdrawal obligation Multiemployer Plans, Withdrawal Obligation Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number of shares under stock awards, outstanding at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Weightedaverage exercise price per share, outstanding at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Number of shares under stock awards, granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Weighted average exercise price per share, granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Number of shares under stock awards, exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Weighted average exercise price per share, exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Number of shares under stock awards, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Weighted average exercise price per share, forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Number of shares under stock awards, outstanding at end of period Weighted average exercise price per share, outstanding at end of period Number of shares under stock awards, vested and expected to vest at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Weighted average exercise price per share, vested and expected to vest at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Number of shares under stock awards, exercisable at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Weighted average exercise price per share, exercisable at period end Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Common stock, par value, in USD per share Common Stock, Par or Stated Value Per Share Common stock, number of shares authorized Common Stock, Shares Authorized Common stock, number of shares issued Common Stock, Shares, Issued Treasury stock, number of shares Treasury Stock, Shares Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventories Principles of Consolidation Policy Consolidation, Policy [Policy Text Block] Use of Estimates in the Preparation of Financial Statements Policy Use of Estimates, Policy [Policy Text Block] Foreign Currencies Policy Foreign Currency Transactions and Translations Policy [Policy Text Block] Cash and Cash Equivalents Policy Cash and Cash Equivalents, Policy [Policy Text Block] Marketable Securities Policy Marketable Securities, Policy [Policy Text Block] Concentrations of Credit Risk Policy Concentration Risk, Credit Risk, Policy [Policy Text Block] Inventories Policy Inventory, Policy [Policy Text Block] Property, Plant and Equipment Policy Property, Plant and Equipment, Policy [Policy Text Block] Intangible Assets and Goodwill Policy Goodwill and Intangible Assets, Policy [Policy Text Block] Intangible Assets and Goodwill Policy Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Contingent Consideration Policy Business Combinations Policy [Policy Text Block] Impairment of Long-Lived Assets Policy Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Revenue Recognition Policy Revenue Recognition, Policy [Policy Text Block] Research and Development Policy Research and Development Expense, Policy [Policy Text Block] Income Taxes Policy Income Tax, Policy [Policy Text Block] Earnings Per Common Share Policy Earnings Per Share, Policy [Policy Text Block] Stock-Based Compensation Policy Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Derivatives Policy Derivatives, Policy [Policy Text Block] Financial Instruments Policy Fair Value of Financial Instruments, Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Legal Costs Policy Legal Costs, Policy [Policy Text Block] Short-term Debt Short-term Debt [Member] Short-Term Borrowings Policy Debt, Policy [Policy Text Block] Total revenues Business Acquisition, Pro Forma Revenue Net earnings attributable to Mylan Inc. common shareholders Business Acquisition, Pro Forma Net Income (Loss) Basic (in USD per share) Business Acquisition, Pro Forma Earnings Per Share, Basic Diluted (in USD per share) Business Acquisition, Pro Forma Earnings Per Share, Diluted Stock Awards Activity Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Nonvested Restricted Stock and Restricted Stock Unit, Including Performance Units, Activity Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Stock-Based Compensation Plans, Valuation Assumptions Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Net earnings Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Stock-based compensation expense Share-based Compensation Change in estimated sales allowances Change in estimated sales allowances The net change during the reporting period in the amount of sales allowances relating to provisions for estimates, including discounts, volume-based sales allowances, price adjustments, returns, chargebacks and other promotional programs. Deferred income tax benefit Deferred Income Tax Expense (Benefit) Loss from equity method investments Income (Loss) from Equity Method Investments Other non-cash items Other Noncash Income (Expense) Litigation settlements, net Change in noncash litigation settlements, net Change in noncash litigation settlements, net Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Trade accounts payable Increase (Decrease) in Accounts Payable, Trade Income taxes Increase (Decrease) in Income Taxes Payable Deferred revenue Increase (Decrease) in Deferred Revenue Other operating assets and liabilities, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Change in restricted cash Increase (Decrease) in Restricted Cash Cash paid for acquisitions, net Payments to Acquire Businesses, Net of Cash Acquired Proceeds from sale of property, plant and equipment Proceeds from Sale of Property, Plant, and Equipment Purchase of marketable securities Payments to Acquire Marketable Securities Proceeds from sale of marketable securities Proceeds from Sale and Maturity of Marketable Securities Payments for product rights and other, net Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Payment of financing fees Payments of Financing Costs Purchase of common stock Payments for Repurchase of Common Stock Change in short-term borrowings, net Proceeds from (Repayments of) Short-term Debt Proceeds from issuance of long-term debt Proceeds from Issuance of Long-term Debt Payment of long-term debt Repayments of Long-term Debt Proceeds from exercise of stock options Proceeds from Stock Options Exercised Taxes paid related to net share settlement of equity awards Payments Related to Tax Withholding for Share-based Compensation Payments for contingent consideration Other items, net Proceeds from (Payments for) Other Financing Activities Net cash (used in) provided by financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations Effect on cash of changes in exchange rates Effect of Exchange Rate on Cash and Cash Equivalents Net decrease in cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and cash equivalents — beginning of period Cash and cash equivalents — end of period Supplemental disclosures of cash flow information — Supplemental Cash Flow Elements [Abstract] Non-cash transactions: Noncash Investing and Financing Items [Abstract] Non-cash transactions Other Significant Noncash Transaction, Value of Consideration Given Cash paid during the period for: Supplemental Cash Flow Information [Abstract] Income taxes Income Taxes Paid Interest Interest Paid Fair value hedging relationships Amount of Gain or (Loss) Recognized in Earnings on Derivatives Mature within one year Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value Mature in one to five years Available-for-sale Securities, Debt Maturities, Year Two Through Five, Fair Value Mature in five years and later Available for Sale Securities Debt Maturities after Five Years and Later Fair Value Available for sale securities debt maturities after five years and later fair value. Available-for-sale securities, debt securities Available-for-sale Securities, Debt Securities Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Effect of Derivative Instruments on the Consolidated Statements of Operations Derivative Instruments, Gain (Loss) [Table Text Block] Financial Assets and Liabilities Carried at Fair Value Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Available-for-Sale Securities Reconciliation Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Maturities Of Available-for-Sale Debt Securities At Fair Value Investments Classified by Contractual Maturity Date [Table Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Asset Class [Axis] Asset Class [Axis] Fair Value by Asset Class [Domain] Asset Class [Domain] Money market funds Money Market Funds [Member] Equity securities — exchange traded funds Exchange Traded Funds [Member] Available-for-sale fixed income investments U.S. Treasuries US Treasury Securities [Member] Corporate bonds Corporate Bond Securities [Member] Agency mortgage-backed securities Collateralized Mortgage Backed Securities [Member] Other Other Debt Obligations [Member] Total available-for-sale equity securities Biosciences industry Common Stock [Member] Interest rate swap derivatives Liability Class [Axis] Liability Class [Axis] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Trading securities Trading Securities Available-for-sale securities Foreign exchange derivative assets Foreign Currency Contract, Asset, Fair Value Disclosure Interest rate swap derivative assets Derivative Asset Convertible debt, fair value disclosures Convertible Debt, Fair Value Disclosures Total assets at recurring fair value measurement Assets, Fair Value Disclosure Foreign exchange derivative liabilities Foreign Currency Contracts, Liability, Fair Value Disclosure Interest rate swap derivative liabilities Derivative Liability Contingent consideration Other Liabilities, Fair Value Disclosure Total liabilities at recurring fair value measurement Financial and Nonfinancial Liabilities, Fair Value Disclosure Reconciliation of Segment Information to Total Consolidated Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Net Revenues Classified Based on Therapeutic Product Categories Revenue from External Customers by Products and Services [Table Text Block] Net Revenues Classified Based on Geographic Location of Customers Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Debt Debt Disclosure [Text Block] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Other long-term obligations Other Long-Term Obligations [Member] Other Long-Term Obligations Equity method investments Equity Method Investments [Member] Investment, Name [Axis] Investment, Name [Axis] Investment, Name [Domain] Investment, Name [Domain] Clean energy investments Clean Energy Partnerships [Member] Clean Energy Partnerships Sagent Agila Sagent Agila [Member] Sagent Agila Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Restricted cash and cash equivalents, current Restricted Cash and Cash Equivalents, Current Restricted cash and cash equivalents Restricted Cash and Cash Equivalents Other Liabilities Other Liabilities Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Statement of Stockholders' Equity [Abstract] Common Stock Additional Paid-In Capital Additional Paid-in Capital [Member] Retained Earnings Retained Earnings [Member] Treasury Stock Treasury Stock [Member] Noncontrolling Interest Noncontrolling Interest [Member] Balance Balance (in shares) Shares, Issued Other comprehensive (loss) earnings, net of tax Other Comprehensive Income (Loss), Net of Tax Common stock share repurchase Common stock share repurchase (in shares) Stock options exercised, net of shares tendered for payment Stock Issued During Period, Value, Stock Options Exercised Stock options exercised, net of shares tendered for payment (in shares) Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock Issued During Period, Value, Stock Options Exercised, Net of Shares Tendered for Payment Stock compensation expense Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Issuance of restricted stock, net of shares withheld Restricted Stock, Value, Shares Issued Net of Tax Withholdings Issuance of restricted stock, net of shares withheld (in shares) Restricted Stock, Shares Issued Net of Shares for Tax Withholdings Tax benefit of stock option plans Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation Other Stockholders' Equity, Other Balance Balance (in shares) Lorazepam and Clorazepate Lorazepam And Clorazepate [Member] Lorazepam And Clorazepate. Found in violation of antitrust laws Found In Violation of Antitrust Laws [Member] Found by jury to be in violation of antitrust laws Health insurers Health Insurers [Member] Health insurers Judgment reflects trebling of compensatory damages Judgment Reflects Trebling Of Compensatory Damages [Member] Judgment reflects trebling of compensatory damages in original verdict Original verdict Original Verdict [Member] Original verdict Original verdict plus punitive damages Original Verdict Plus Punitive Damages [Member] Original verdict plus punitive damages Self-funded customers voluntarily dismissed Self-funded Customers Voluntarily Dismissed [Member] Self-funded customers voluntarily dismissed Self-funded customers Self-Funded Customers [Member] Self-funded customers Bond Surety Bond [Member] Number of drugs Number of drugs Number of drugs Number of plaintiffs Loss Contingency, Number of Plaintiffs Damages sought Loss Contingency, Damages Sought, Value Voluntary remittitur from plaintiffs Voluntary remittitur from plaintiffs The voluntary remittitur from plaintiffs Bond Bond, Value Bond, value Net unrealized gains on marketable securities, net of tax Net unrecognized losses and prior service cost related to defined benefit plans, net of tax Net unrecognized (losses) gains on derivatives, net of tax Foreign currency translation adjustment Accumulated other comprehensive loss Valuation and Qualifying Accounts Disclosure [Table] Valuation and Qualifying Accounts Disclosure [Table] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves Type [Axis] Valuation Allowances and Reserves [Domain] Valuation Allowances and Reserves [Domain] Valuation and Qualifying Accounts Disclosure [Line Items] Valuation and Qualifying Accounts Disclosure [Line Items] Statement of Comprehensive Income [Abstract] Other comprehensive (loss) earnings, before tax: Other Comprehensive Income (Loss), before Tax [Abstract] Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Net unrecognized (loss) gain on derivatives Other comprehensive (loss) earnings, before tax Income tax (benefit) provision Other Comprehensive Income (Loss), Tax Other comprehensive (loss) earnings, net of tax Comprehensive earnings Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Comprehensive earnings attributable to the noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Comprehensive earnings attributable to Mylan Inc. common shareholders Comprehensive Income (Loss), Net of Tax, Attributable to Parent Quarterly Financial Data [Table] Schedule of Quarterly Financial Information [Table] Schedule of Quarterly Financial Information [Table] Quarterly Financial Data [Line Items] Quarterly Financial Information [Line Items] Quarterly Financial Information [Line Items] Total revenues Gross profit Share prices, high Market Price Per Share High High closing market price per share. Share prices, low Market Price Per Share Low Low closing market price per share. Income Taxes Income Tax Disclosure [Text Block] Quarterly Financial Data Schedule of Quarterly Financial Information [Table Text Block] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Restricted Stock Awards Restricted Stock Units (RSUs) [Member] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Number of restricted stock awards, nonvested beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Weighted average grant-date fair value per share, nonvested beginning balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted average grant-date fair value per share, granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Number of restricted stock awards, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Weighted average grant-date fair value per share, released Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Number of restricted stock awards, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Weighted average grant-date fair value per share, forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Number of restricted stock awards, nonvested ending balance Weighted average grant-date fair value per share, nonvested ending balance Customer relationships Customer Relationships [Member] Purchase consideration, cash paid Gain recognized related to contingent consideration Research and development in process, expect completion cost Expected cost to complete Expected cost to complete Equity method investment Amount of goodwill expected to be tax deductible Business Acquisition, Goodwill, Expected Tax Deductible Amount Goodwill and Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Subfacility for letters of credit Subfacility for Letters of Credit [Member] Subfacility for Letters of Credit Subfacility for swingline borrowings Subfacility for Swing Line Borrowings [Member] Subfacility for Swing Line Borrowings Line of credit Line of Credit [Member] New Revolving Facility New Revolving Facility [Member] New Revolving Facility Revolving Facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Revolving facility interest rate Line of Credit Facility, Interest Rate During Period Facility fee Line of Credit Facility, Commitment Fee Percentage Revolving facility amount outstanding Line of Credit Facility, Fair Value of Amount Outstanding Term loan interest rate Debt Instrument, Interest Rate During Period Write-off of deferred financing fees Write off of Deferred Debt Issuance Cost Allowance for doubtful accounts Allowance for Doubtful Accounts [Member] Valuation allowance for deferred tax assets Valuation Allowance of Deferred Tax Assets [Member] Movement in Valuation Allowances and Reserves [Roll Forward] Movement in Valuation Allowances and Reserves [Roll Forward] Beginning balance Valuation Allowances and Reserves, Balance Additions Charged to Costs and Expenses Valuation Allowances and Reserves, Charged to Cost and Expense Additions Charged to Other Accounts Valuation Allowances and Reserves, Charged to Other Accounts Deductions Valuation Allowances and Reserves, Deductions Ending balance Schedule of Goodwill [Table] Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill [Line Items] Goodwill, gross, beginning balance Goodwill, Gross Accumulated impairment losses, beginning balance Goodwill, Impaired, Accumulated Impairment Loss Goodwill, net, beginning balance Acquisitions Goodwill, Acquired During Period Transfers Goodwill, Other Changes Divestment Goodwill, Written off Related to Sale of Business Unit Foreign currency translation Goodwill, Translation and Purchase Accounting Adjustments Goodwill, gross, ending balance Accumulated impairment losses, ending balance Goodwill, net, ending balance